Schear Investment Advisers LLC boosted its holdings in The Clorox Company (NYSE:CLX – Free Report) by 5.5% during the fourth quarter, Holdings Channel reports. The fund owned 8,374 shares of the company’s stock after purchasing an additional 434 shares during the period. Schear Investment Advisers LLC’s holdings in Clorox were worth $1,360,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also added to or reduced their stakes in the company. Brooklyn Investment Group lifted its stake in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after buying an additional 95 shares during the last quarter. Prospera Private Wealth LLC acquired a new stake in Clorox during the third quarter worth approximately $27,000. Continuum Advisory LLC boosted its holdings in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares during the period. Carolina Wealth Advisors LLC acquired a new position in shares of Clorox in the third quarter valued at approximately $48,000. Finally, Friedenthal Financial bought a new position in shares of Clorox during the third quarter worth approximately $49,000. Institutional investors and hedge funds own 78.53% of the company’s stock.
Analyst Ratings Changes
Several research firms have weighed in on CLX. Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Wells Fargo & Company boosted their price objective on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Barclays lifted their price target on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research report on Wednesday, February 5th. Finally, Evercore ISI raised their price objective on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, Clorox currently has a consensus rating of “Hold” and a consensus price target of $158.21.
Clorox Trading Up 0.9 %
CLX opened at $148.47 on Wednesday. The company has a market cap of $18.38 billion, a P/E ratio of 40.56, a PEG ratio of 2.52 and a beta of 0.42. The company has a current ratio of 0.94, a quick ratio of 0.62 and a debt-to-equity ratio of 20.52. The company’s 50 day moving average is $160.68 and its 200-day moving average is $159.16. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37.
Clorox (NYSE:CLX – Get Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the previous year, the firm earned $2.16 EPS. Equities research analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Clorox Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 3.29%. Clorox’s dividend payout ratio is presently 133.33%.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- How to buy stock: A step-by-step guide for beginnersÂ
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- What Makes a Stock a Good Dividend Stock?
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- How to Calculate Inflation Rate
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.